skip to main content

Tübingen Environmental Researcher Lars Angenent Receives the Leibniz Prize

German Research Foundation honors scientist for groundbreaking research in environmental biotechnology

08.12.2022 Press Release

Tübingen biotechnologist Lars Angenent is being awarded the Leibniz Prize by the German Research Foundation (DFG) in appreciation of his outstanding work in the field of environmental biotechnology, it was announced in Bonn on Thursday. The DFG said:

„In view of climate change and the resulting need to develop a sustainable food, chemistry and energy economy, his work is highly relevant.“

Lars Angenent has held the Humboldt Professorship at the Environmental and Geoscience Center (GUZ) of the University of Tübingen since 2016. He develops innovative bio-processes for the conversion of organic waste and industrial waste gas into renewable fuels, green chemicals and sustainable foodstuffs. For example, using recycled carbon dioxide he produces edible proteins that can be used as a meat substitute.

In another of his research projects, he “feeds” carbon dioxide and hydrogen to microbes, thereby producing methane which can be passed into the gas network. The energy needed for this comes from sustainable sources such as wind power. If used at an industrial level this could eventually reduce the CO2 content of the atmosphere. Lars Angenent has already tested the process with a start-up, Electrochaea, that he co-founded.

“Science can make a decisive contribution to solving the urgent problems of our time. The awarding of the Leibniz Prize to Lars Angenent honors his groundbreaking efforts in environmental research,” says Professor Karla Pollmann, President of the University of Tübingen. “What is especially impressive about Lars Angenent’s work is his ability to research globally relevant processes from their microbiological principles through to industrial application and break new ground.”

About the awardee

Lars Angenent was born in the Netherlands in 1969 and studied environmental biotechnology at Wageningen University. He took his doctorate at Iowa State University in the USA. In 2002 he went to Washington University in St. Louis as assistant professor, after which he was called upon to move to Cornell University. In 2016 he received the Humboldt Professorship and moved to Tübingen.

The USA National Science Foundation has already honored Lars Angenent with a Career Award. This summer he also became a Fellow of the International Society for Microbial Electrochemistry and Technology (ISMET).

Lars Angenent is Principal Investigator at the Cluster of Excellence CMFI. 

 

About the Leibniz Prize

The Gottfried Wilhelm Leibniz Prize is the most important research funding award in Germany. The Leibniz program was established in 1985 and aims to improve the working conditions of outstanding scientists, expand their opportunities for research, relieve them of their administrative burden and make it easier to engage highly qualified junior scientists. The prize brings with it up to 2.5 million euros. Since 1985 a total of 18 researchers from the University of Tübingen and the Tübingen Max Planck Institute have been awarded the Leibniz Prize.

Scientific Contact

Prof. Dr. Ir.  Largus  T.  Angenent

University of Tübingen
Zentrum für Angewandte Geowissenschaften
Umweltbiotechnologie

l.angenent@uni-tuebingen.de

Website

 

Press Contact

Leon Kokkoliadis
Public Relations Management

Tel: +49 7071 29-74707
E-Mail: leon.kokkoliadis@uni-tuebingen.de

Related Articles

Power-to-vitamins: microbes produce folate from simple basic ingredients
12.09.2024 Power-to-vitamins: microbes produce folate from simple basic ingredients Press Release
New Podcasts with Hannes Link and Eric Kemen
10.09.2024 New Podcasts with Hannes Link and Eric Kemen CMFI News
CMFI Mediathek Launch
09.09.2024 CMFI Mediathek Launch CMFI News
Nasal microbiome: depriving multi-resistant bugs of iron
05.08.2024 Nasal microbiome: depriving multi-resistant bugs of iron Press Release
Phage lysin compound HY-133: Start of clinical phase I
30.07.2024 Phage lysin compound HY-133: Start of clinical phase I Press Release
Samuel Wagner Elected Vice-President
25.07.2024 Samuel Wagner Elected Vice-President Press Release